Head and neck cancer, treatment, evolution and post therapeutic survival - Part 2: a decade's results 1993-2002

J Craniomaxillofac Surg. 2007 Mar;35(2):126-31. doi: 10.1016/j.jcms.2007.02.002. Epub 2007 Apr 20.

Abstract

Introduction and objectives: In the second part of an analysis of a 10-year period of treating oral cancer patients, the focus was the efficiency of treatment, recurrence rates and survival.

Patients and methods: From 1485 patients with oral and maxillofacial malignant tumours, 1072 cases could be evaluated. The following data were analyzed statistically: patients' charts and medical records including the follow-up reports.

Results: From all patients studied, 811 underwent surgical treatment alone, the mean recurrence rate was 23%. The recurrence rate after surgery plus radiotherapy was 38%; after surgical treatment alone it was 23%; the survival rate at 3 and 5 years post-therapeutically was 49% and 31%, respectively.

Conclusions: The first choice therapy for carcinomas is surgical. The recurrence rate increased with lymph node involvement and tumour size.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Carcinoma, Basal Cell / mortality*
  • Carcinoma, Basal Cell / therapy
  • Carcinoma, Squamous Cell / mortality*
  • Carcinoma, Squamous Cell / therapy
  • Combined Modality Therapy / methods
  • Female
  • Head and Neck Neoplasms / mortality*
  • Head and Neck Neoplasms / therapy
  • Humans
  • Kaplan-Meier Estimate
  • Male
  • Middle Aged
  • Neoplasm Recurrence, Local / mortality
  • Romania / epidemiology